| |
Preface |
ix |
| |
Acknowledgements |
xi |
| Chapter 1 |
Introduction |
1 |
| |
The Business of Diagnostic Testing |
1 |
| |
Quality Has Improved--Yet
Physicians Rely More on Test Results |
1 |
| |
Lifescan: One Manufacturer's
Problem |
1 |
| |
University of Washington Medical
Center: A Laboratory Problem |
2 |
| |
Analysis of the Two Problems |
2 |
| |
Why Problems Occur |
3 |
| |
Financial Incentives Don't Favor
Allocating Resources to Quality |
3 |
| |
Industry-supported Studies Favor
Low-information-content Reports |
4 |
| |
Corporate Culture |
4 |
| |
Inertia |
4 |
| |
How This Book Can Help |
5 |
| Appendix |
The Role of Assay Error in Decisions to
Approve Assays for Use |
6 |
| Chapter 2 |
The Diagnostic Assay Development Landscape
and the Role of Consultants |
7 |
| |
The Technical Environment |
7 |
| |
The Commercial Environment |
8 |
| |
The Regulatory and Medical
Environment |
8 |
| |
The Management Environment |
8 |
| |
The Five Stages of Product
Development |
9 |
| |
The Consultant's Environment--How
Consultants Get Their Solutions Implemented |
10 |
| |
How Statisticians Are Often
Perceived and What They Really Do |
10 |
| |
When Management Resists--Techniques
Used by Consultants to Implement Solutions |
11 |
| |
It's About Control |
12 |
| |
The Successful Consulting Cycle |
13 |
| |
Technology Transfer--The Benefits
of a Learning Organization |
13 |
| |
Training as Part of a Learning
Organization |
14 |
| Chapter 3 |
Stage I: Researching New Opportunities |
17 |
| |
Why Scientists and Engineers Need
to Understand Financial Models |
17 |
| |
Using Decision-analysis-based
Financial Models to Value Opportunities |
18 |
| |
Decision-analysis Background and
Terms |
18 |
| |
Selecting Decision-analysis
Software |
19 |
| |
Creating the Decision-analysis Team |
19 |
| |
Preparing an Influence Diagram |
19 |
| |
Techniques to Solicit Unbiased Data |
21 |
| |
Performing the Analysis--The
Results |
22 |
| |
The Base Case |
22 |
| |
Sensitivity Analysis |
22 |
| |
Distribution Analysis |
23 |
| |
Techniques to Improve
Decision-analysis Models |
24 |
| |
The Use of Options |
24 |
| |
Markov Analysis |
25 |
| |
Methods to Evaluate the Probability
of the Technical Success of Opportunities |
27 |
| |
Different States of Knowledge
Require Different Strategies |
28 |
| |
Results Based on Decision Analysis |
28 |
| |
Why Management Always Wants the
Product Released Sooner |
28 |
| |
Why Quality Ranks Low in Terms of
Financial Rewards |
30 |
| |
Portfolio Analysis |
31 |
| |
A Caveat About Using Decision
Analysis |
31 |
| Appendix |
How Expected NPVs Are Calculated |
31 |
| Chapter 4 |
Stage II: Proving Feasibility |
33 |
| |
Setting Performance Specifications
Using Quantitative Methods |
33 |
| |
The Importance of Adequate
Performance Specifications |
33 |
| |
Adequate and Less-than-adequate
Performance Specifications |
34 |
| |
Nonexistent Specifications |
34 |
| |
Nonquantitative Specifications |
35 |
| |
Unrealistic Specifications |
35 |
| |
Incorrect Specifications |
36 |
| |
Specifications Without an
Associated Testing and Analysis Method |
36 |
| |
Characteristics of an Adequate
Performance Specification |
37 |
| |
An Example of a Performance
Specification for Blood Gas Analyzer Glucose Imprecision |
37 |
| |
How Specifications Change Through
the Development Process |
37 |
| |
Different Origins of Performance
Specifications |
37 |
| |
Regulatory |
38 |
| |
Medical Need |
38 |
| |
Competitive |
38 |
| |
How Specifications Are Used
Differently by Manufacturers and Customers |
39 |
| |
Specific Techniques Used to Set
Performance Specifications |
40 |
| |
Focus Groups and Surveys |
40 |
| |
Conjoint Analysis |
41 |
| |
Quality Function Deployment |
42 |
| |
Different Approaches to
Demonstrating Feasibility |
45 |
| |
Beware the Technical Administrator |
45 |
| Chapter 5 |
Stage III: Scheduled Development |
49 |
| |
Why Products Are Almost Always Late |
49 |
| |
Using Design of Experiments Methods
to Build Robust Assays |
52 |
| |
Why Many Scientists Do not Use
Design of Experiments (DOE) Methods |
52 |
| |
Cause-and-effect Diagrams and
Process Flow Charts |
53 |
| |
Factorial and Response-surface
Methods |
54 |
| |
Experiment-planning Checklist |
56 |
| |
Writing Reports That Convert Data
into Information |
57 |
| |
The Need for Written Reports |
57 |
| |
Tips for Converting Data into
Information |
57 |
| |
A Suggested Report Format |
58 |
| |
Symptoms for Problem Reports |
59 |
| |
Using Reliability Growth Management
to Build Reliable Systems |
59 |
| |
An Overview of Reliability Growth
Management |
60 |
| |
When "Testing in Quality" Is More
Efficient Than "Designing in Quality" |
61 |
| |
A Model of Instrument System
Service Calls |
61 |
| |
Redundancy and Reliability Goals |
62 |
| |
FRACAS |
62 |
| |
Data Analysis |
63 |
| |
Corrective Action |
63 |
| |
Measuring Progress |
64 |
| |
Results Achieved with Reliability
Growth Management |
66 |
| Chapter 6 |
Stage IV: Validation |
69 |
| |
Why Many Published Validation
Methods Fall Short in Assessing Assay Quality |
69 |
| |
Validation Methods Within Companies |
69 |
| |
Error Modeling Using Simulation |
69 |
| |
A Block Diagram or Flow Chart of
the System |
70 |
| |
A Cause-and-effect Diagram of Error |
70 |
| |
How the Error Model Works |
71 |
| |
The Simulation Software |
72 |
| |
Total Analytical Error |
72 |
| |
Multifactor Protocols |
76 |
| |
Introduction |
76 |
| |
Multifactor Protocol History |
76 |
| |
Understanding Multifactor Protocols |
76 |
| |
Use and Interpretation of
Multifactor Protocols |
79 |
| |
Examples |
79 |
| |
Implementation |
82 |
| |
Additional Special Studies |
82 |
| |
Diagnostic Accuracy |
82 |
| |
The Detection Limit |
83 |
| |
Specific Interference Studies |
83 |
| |
Direct vs. Indirect Methods of
Estimation |
83 |
| |
Estimation of Outliers |
83 |
| |
Outlier Goals |
84 |
| |
Estimation of Outlier Rates |
85 |
| |
External (Customer) Validation
Methods |
88 |
| |
Why Manufacturer Trials Held at
Customer Sites Often Fail to Detect Problems |
88 |
| Chapter 7 |
Stage V: Commercialization |
91 |
| |
How Claims Differ from Internal
Specifications |
91 |
| |
The Typical Data Claim |
91 |
| |
The Guaranteed Performance Claim |
92 |
| |
Obtaining and Analyzing Remote Data |
93 |
| |
Fault Detection |
93 |
| |
Data Collection |
93 |
| |
Data Analysis |
94 |
| |
The Mean Cumulative Repair Function |
94 |
| |
Using Process Capability to Compare
Performance Across Assays |
96 |
| |
The Difference Between Quality
Control and Process Capability |
97 |
| |
An Example Set of Assays Compared |
97 |
| |
Interpretation |
98 |
| |
Using Complaints to Improve Assays |
101 |
| |
Index |
103 |